Ashleigh E. Moore
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA Research and Splicing
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA and protein synthesis mechanisms
Papers in
-
- NF-κB Signaling Pathways 2
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- Dan A. Dixon (5 shared papers)Lisa Young (3 shared papers)Nicole Meisner‐Kober (1 shared paper)Lena Sokol (1 shared paper)Robert J. Schneider (1 shared paper)Devon Chenette (1 shared paper)Joseph R. Iacona (1 shared paper)Carol S. Lutz (1 shared paper)
- Journals
- Scientific Reports (1 paper)Faraday Discussions (1 paper)British Journal of Pharmacology (1 paper)Cancer and Metastasis Reviews (1 paper)Molecular Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Ashleigh E. Moore
8 papers receiving 360 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 157
- Molecular Biology 226
- Pharmacology 39
- Inorganic Chemistry 23
- Oncology 20
Countries citing papers authored by Ashleigh E. Moore
This map shows the geographic impact of Ashleigh E. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh E. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh E. Moore more than expected).
Fields of papers citing papers by Ashleigh E. Moore
This network shows the impact of papers produced by Ashleigh E. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh E. Moore. The network helps show where Ashleigh E. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashleigh E. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 162 | |
| 2 | 2014 | 67 | |
| 3 | 2011 | 44 | |
| 4 | 2021 | 33 | |
| 5 | 2019 | 24 | |
| 6 | 2011 | 18 | |
| 7 | 2015 | 9 | |
| 8 | 2016 | 5 |
About Ashleigh E. Moore
Ashleigh E. Moore is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Sociology and Political Science and Management, Monitoring, Policy and Law, having authored 8 papers that have together received 362 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), NF-κB Signaling Pathways (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers), RNA Research and Splicing (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Industrial Gas Emission Control (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (157 citations), Molecular Biology (226 citations), Pharmacology (39 citations), Inorganic Chemistry (23 citations) and Oncology (20 citations). Ashleigh E. Moore has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Dan A. Dixon, Lisa Young, Nicole Meisner‐Kober, Lena Sokol, Robert J. Schneider, Devon Chenette, Joseph R. Iacona, Carol S. Lutz, Stuart L. James and Yuancheng Zhang. Their work appears in journals such as Scientific Reports, Faraday Discussions, British Journal of Pharmacology, Cancer and Metastasis Reviews and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.